Centre, Israel Oct 8, 2025 – ProSpec, a protein specialist, supports global medical sectors and advanced research with its high-quality, medical-grade prokaryotic and eukaryotic protein production. With over 20 years of experience in recombinant protein manufacturing, the company utilizes proprietary purification technologies. Its team of experienced biochemists and biotechnologists is dedicated to producing a diverse product portfolio with low production costs, high yield, and exceptional purity. These products maintain biological activity and deliver impactful results.

The company aims to supply highly purified protein products worldwide, benefiting medical sectors and research facilities. ProSpec’s advanced protein products support advancements in various fields, including cancer, endocrinology, immunology, apoptosis, neuroscience, proteases, and stem cell studies. The company has a proven track record of reliably supplying proteins for research, development, and further manufacturing, acting as a supply chain link for biotech companies and academic/research institutions globally.

ProSpec offers a large portfolio of recombinant proteins designed for academic and R&D purposes. With over two decades of experience, the company has developed more than 6000 recombinant proteins, peptides, and antibodies for the global research community. Its portfolio includes recombinant proteins, cytokines, growth factors, chemokines, hormones, enzymes, and viral antigens, among others. Key products include interferons, interleukins, BMPs, TNFs, FGFs, leptins, prolactins, PDGFs, EGFs, IGFs, NGFs, HGFs, VEGFs, CSFs, TGFs, and angiopoietins. This diverse product line meets the unique needs of various clients.

Dr. Tanchum Amarant, known as Tany, founded ProSpec and helped it become a global leader in life science research. The company collaborates with researchers and scientists to meet their needs while expanding its protein portfolio. Through collaboration and teamwork, ProSpec serves a wide range of customers worldwide, including biotech and pharma companies, hospitals, laboratories, and academic and government institutions. The company serves regions in North America, South America, Western Europe, Eastern Europe, Southern Asia, Eastern Asia, and Southeast Asia. ProSpec’s global customer base includes Kyoto University, University of Tokyo, IBP, University of Warsaw, Boston University, Duke University, Harvard University, Unicamp, The University of Adelaide, The University of Sydney, NCBS, UMG, and Jacob University, and the company aims to expand further.

ProSpec aims to empower scientific developments through collaboration with researchers, scientists, and the bioindustry. Its mission is to advance life science research by offering a wide range of high-quality proteins, and it is seeking distribution partners for expansion. Visit the official website at to learn more.